<DOC>
	<DOCNO>NCT00380744</DOCNO>
	<brief_summary>The purpose study examine safety efficacy antibody rheumatoid arthritis patient . Part A study initial dose escalation phase Part B study randomize allocation entire dose group parallel treatment assignment</brief_summary>
	<brief_title>A Safety Pharmacokinetics Study Patients With Rheumatoid Arthritis</brief_title>
	<detailed_description />
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Arthritis , Rheumatoid</mesh_term>
	<criteria>diagnosis rheumatoid arthritis regular use methotrexate active rheumatoid arthritis Juvenile Rheumatoid Arthritis evidence tuberculosis woman pregnant become pregnant study , breastfeed</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2009</verification_date>
</DOC>